<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>Myomo</title>
	<atom:link href="https://myomo.com/feed/" rel="self" type="application/rss+xml" />
	<link>https://myomo.com/</link>
	<description>The MyoPro Brace for Stroke Survivor&#039;s Paralyzed Arm</description>
	<lastBuildDate>Fri, 27 Mar 2026 22:10:42 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://myomo.com/wp-content/uploads/2025/01/cropped-Untitled-design-25-32x32.png</url>
	<title>Myomo</title>
	<link>https://myomo.com/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Myomo and Elevance Health Agree to Contract for Multi-State Network Participation</title>
		<link>https://myomo.com/myomo-and-elevance-health-agree-to-contract-for-multi-state-network-participation/</link>
					<comments>https://myomo.com/myomo-and-elevance-health-agree-to-contract-for-multi-state-network-participation/#respond</comments>
		
		<dc:creator><![CDATA[Ian Godzik]]></dc:creator>
		<pubDate>Mon, 09 Mar 2026 20:15:59 +0000</pubDate>
				<category><![CDATA[Press Release]]></category>
		<guid isPermaLink="false">https://myomo.com/?p=5021184</guid>

					<description><![CDATA[<p>BURLINGTON, Mass. (March 9, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced today it has entered into its first among a series of expected network participation agreements with Elevance Health.  The contracts, which include [&#8230;]</p>
<p>The post <a href="https://myomo.com/myomo-and-elevance-health-agree-to-contract-for-multi-state-network-participation/">Myomo and Elevance Health Agree to Contract for Multi-State Network Participation</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><strong>BURLINGTON, Mass. (March 9, 2026)</strong> – <strong>Myomo, Inc. (NYSE American: MYO)</strong> (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced today it has entered into its first among a series of expected network participation agreements with Elevance Health.  The contracts, which include the Anthem-affiliated Commercial, Medicare Advantage, and Medicaid plans are expected to become effective on a market-by-market basis through the second quarter of 2026.  Once complete, the addition of these 45 million medical members will bring Myomo’s total number of covered lives under commercial insurance plans to over 80 million. <a href="https://myomo.com/wp-content/uploads/2026/03/Myomo-Announces-Partnership-With-Elevance-Health.pdf">Read more.</a></p>
<p>The post <a href="https://myomo.com/myomo-and-elevance-health-agree-to-contract-for-multi-state-network-participation/">Myomo and Elevance Health Agree to Contract for Multi-State Network Participation</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://myomo.com/myomo-and-elevance-health-agree-to-contract-for-multi-state-network-participation/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		
	</item>
		<item>
		<title>Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results</title>
		<link>https://myomo.com/myomo-reports-fourth-quarter-and-full-year-2025-financial-and-operating-results/</link>
					<comments>https://myomo.com/myomo-reports-fourth-quarter-and-full-year-2025-financial-and-operating-results/#respond</comments>
		
		<dc:creator><![CDATA[Ian Godzik]]></dc:creator>
		<pubDate>Mon, 09 Mar 2026 20:14:34 +0000</pubDate>
				<category><![CDATA[Press Release]]></category>
		<guid isPermaLink="false">https://myomo.com/?p=5021181</guid>

					<description><![CDATA[<p>Fourth quarter revenue of $11.4 million, full year revenue of $40.9 million 42% of fourth quarter revenue from recurring patient sources  Record 241 authorizations and orders in the quarter   Introduces 2026 revenue guidance of $43 million to $46 million as Company emphasizes recurring sources of revenue   Conference call begins today at 4:30pm Eastern [&#8230;]</p>
<p>The post <a href="https://myomo.com/myomo-reports-fourth-quarter-and-full-year-2025-financial-and-operating-results/">Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><em>Fourth quarter revenue of $11.4 million, full year revenue of $40.9 million</em></p>
<p><em>42% of fourth quarter revenue from recurring patient sources </em></p>
<p><em> Record 241 authorizations and orders in the quarter</em></p>
<p><em>  Introduces 2026 revenue guidance of $43 million to $46 million as Company emphasizes recurring sources of revenue</em></p>
<p><em> </em></p>
<p><em>Conference call begins today at 4:30pm Eastern time</em></p>
<p><em> </em></p>
<p><strong>BURLINGTON, Mass. (March 9, 2026) – Myomo, Inc. (NYSE American: MYO)</strong> (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months and year ended December 31, 2025.</p>
<p>“We delivered 2025 revenue at the midpoint of our updated guidance range with record fourth quarter revenues from the U.S. orthotics and prosthetics (&#8220;O&amp;P&#8221;) and International sales channels.  We also achieved our strongest quarter of the year for MyoPro authorizations and orders,&#8221; said Paul Gudonis, Myomo&#8217;s Chairman and Chief Executive Officer.  &#8220;We look forward to improved results from our 2026 marketing initiatives as we place greater emphasis on referrals and other recurring patient sources with a lower customer acquisition cost.&#8221; <a href="https://myomo.com/wp-content/uploads/2026/03/Myomo-Q425-Earnings-PR.pdf">Read more.</a></p>
<p>The post <a href="https://myomo.com/myomo-reports-fourth-quarter-and-full-year-2025-financial-and-operating-results/">Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://myomo.com/myomo-reports-fourth-quarter-and-full-year-2025-financial-and-operating-results/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		
	</item>
		<item>
		<title>Myomo to Report Fourth Quarter 2025 Financial Results on March 9</title>
		<link>https://myomo.com/myomo-to-report-fourth-quarter-2025-financial-results-on-march-9/</link>
					<comments>https://myomo.com/myomo-to-report-fourth-quarter-2025-financial-results-on-march-9/#respond</comments>
		
		<dc:creator><![CDATA[Ian Godzik]]></dc:creator>
		<pubDate>Mon, 02 Mar 2026 21:10:11 +0000</pubDate>
				<category><![CDATA[Press Release]]></category>
		<guid isPermaLink="false">https://myomo.com/?p=5021152</guid>

					<description><![CDATA[<p>BURLINGTON, Mass. (March 2, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the fourth quarter and year ended December 31, 2025 on Monday, March 9, [&#8230;]</p>
<p>The post <a href="https://myomo.com/myomo-to-report-fourth-quarter-2025-financial-results-on-march-9/">Myomo to Report Fourth Quarter 2025 Financial Results on March 9</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><strong>BURLINGTON, Mass. (March 2, 2026) – Myomo, Inc.</strong> (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the fourth quarter and year ended December 31, 2025 on Monday, March 9, 2026.  Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions. <a href="https://myomo.com/wp-content/uploads/2026/03/Myomo-Inc.-Press-Release-3-2-26.pdf">Read More</a>.</p>
<p>The post <a href="https://myomo.com/myomo-to-report-fourth-quarter-2025-financial-results-on-march-9/">Myomo to Report Fourth Quarter 2025 Financial Results on March 9</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://myomo.com/myomo-to-report-fourth-quarter-2025-financial-results-on-march-9/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		
	</item>
		<item>
		<title>Myomo Reports Third Quarter 2025 Financial and Operating Results</title>
		<link>https://myomo.com/myomo-reports-third-quarter-2025-financial-and-operating-results/</link>
					<comments>https://myomo.com/myomo-reports-third-quarter-2025-financial-and-operating-results/#respond</comments>
		
		<dc:creator><![CDATA[Ian Godzik]]></dc:creator>
		<pubDate>Mon, 10 Nov 2025 21:05:25 +0000</pubDate>
				<category><![CDATA[Press Release]]></category>
		<guid isPermaLink="false">https://myomo.com/?p=5020863</guid>

					<description><![CDATA[<p>Revenue of $10.1 million 229 authorizations and orders, highest number this year Reiterates full year revenue guidance of $40 million to $42 million   Conference call begins today at 4:30pm Eastern time   BURLINGTON, Mass. (November 10, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers [&#8230;]</p>
<p>The post <a href="https://myomo.com/myomo-reports-third-quarter-2025-financial-and-operating-results/">Myomo Reports Third Quarter 2025 Financial and Operating Results</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><em>Revenue of $10.1 million </em></p>
<p><em>229 authorizations and orders, highest number this year </em></p>
<p><em>Reiterates full year revenue guidance of $40 million to $42 million</em></p>
<p><em> </em></p>
<p><em>Conference call begins today at 4:30pm Eastern time</em></p>
<p><em> </em></p>
<p><strong>BURLINGTON, Mass. (November 10, 2025) – Myomo, Inc. (NYSE American: MYO)</strong> (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and nine months ended September 30, 2025. <a href="https://myomo.com/wp-content/uploads/2025/11/Q3-2025-Earnings.pdf">Read more.</a></p>
<p>The post <a href="https://myomo.com/myomo-reports-third-quarter-2025-financial-and-operating-results/">Myomo Reports Third Quarter 2025 Financial and Operating Results</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://myomo.com/myomo-reports-third-quarter-2025-financial-and-operating-results/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		
	</item>
		<item>
		<title>Myomo to Report Third Quarter 2025 Financial Results on November 10</title>
		<link>https://myomo.com/myomo-to-report-third-quarter-2025-financial-results-on-november-10/</link>
					<comments>https://myomo.com/myomo-to-report-third-quarter-2025-financial-results-on-november-10/#respond</comments>
		
		<dc:creator><![CDATA[Ian Godzik]]></dc:creator>
		<pubDate>Mon, 03 Nov 2025 21:15:20 +0000</pubDate>
				<category><![CDATA[Press Release]]></category>
		<guid isPermaLink="false">https://myomo.com/?p=5020852</guid>

					<description><![CDATA[<p>BURLINGTON, Mass. (November 3, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the third quarter of 2025 on Monday, November 10, 2025.  Management will hold [&#8230;]</p>
<p>The post <a href="https://myomo.com/myomo-to-report-third-quarter-2025-financial-results-on-november-10/">Myomo to Report Third Quarter 2025 Financial Results on November 10</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><strong>BURLINGTON, Mass. (November 3, 2025) – Myomo, Inc.</strong> (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the third quarter of 2025 on Monday, November 10, 2025.  Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions.<a href="https://myomo.com/wp-content/uploads/2025/11/Myomo-Inc-PR-11-3-25.pdf"> Read more.</a></p>
<p>The post <a href="https://myomo.com/myomo-to-report-third-quarter-2025-financial-results-on-november-10/">Myomo to Report Third Quarter 2025 Financial Results on November 10</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://myomo.com/myomo-to-report-third-quarter-2025-financial-results-on-november-10/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		
	</item>
		<item>
		<title>Myomo at H.C. Wainwright 27th Global Conference</title>
		<link>https://myomo.com/myomo-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference/</link>
					<comments>https://myomo.com/myomo-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference/#respond</comments>
		
		<dc:creator><![CDATA[Ian Godzik]]></dc:creator>
		<pubDate>Tue, 02 Sep 2025 20:30:54 +0000</pubDate>
				<category><![CDATA[Press Release]]></category>
		<guid isPermaLink="false">https://myomo.com/?p=5020803</guid>

					<description><![CDATA[<p>BURLINGTON, Mass. (September 2, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer, and David Henry, chief financial officer, will present at the H.C. Wainwright [&#8230;]</p>
<p>The post <a href="https://myomo.com/myomo-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference/">Myomo at H.C. Wainwright 27th Global Conference</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><strong>BURLINGTON, Mass. (September 2, 2025) – Myomo, Inc. (NYSE American: MYO)</strong> (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer, and David Henry, chief financial officer, will present at the H.C. Wainwright 27<sup>th</sup> Annual Global Investment Conference taking place September 8-10, 2025 at the Lotte New York Palace Hotel. A Company presentation will be available on demand for conference participants and management will be available for virtual one-on-one meetings with investors registered for the event. <a href="https://myomo.com/wp-content/uploads/2025/09/Myomo-to-Present-at-the-H.C.-Wainwright-27th-Annual-Global-Investment-Conference.pdf" target="_blank" rel="noopener">Read More</a>.</p>
<p>The post <a href="https://myomo.com/myomo-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference/">Myomo at H.C. Wainwright 27th Global Conference</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://myomo.com/myomo-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		
	</item>
		<item>
		<title>Webinars</title>
		<link>https://myomo.com/webinars/</link>
					<comments>https://myomo.com/webinars/#respond</comments>
		
		<dc:creator><![CDATA[Ian Godzik]]></dc:creator>
		<pubDate>Tue, 02 Sep 2025 19:31:41 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://myomo.com/?p=5020792</guid>

					<description><![CDATA[<p>Myomo Webinar Series Stay Informed. Stay Connected. Stay Ahead. Join us for an exclusive three-part webinar series designed to equip clinicians, providers, and industry partners with the knowledge and tools to maximize the benefits of the MyoPro® 2x. Each session dives into a critical area to help you succeed—whether it’s navigating reimbursement, discovering what’s new, [&#8230;]</p>
<p>The post <a href="https://myomo.com/webinars/">Webinars</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="5020792" class="elementor elementor-5020792" data-elementor-post-type="post">
						<section class="elementor-section elementor-top-section elementor-element elementor-element-c073d4c elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="c073d4c" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-66f656f" data-id="66f656f" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-5a2c99e elementor-widget elementor-widget-text-editor" data-id="5a2c99e" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<h1 data-start="262" data-end="286">Myomo Webinar Series</h1><h3 data-start="287" data-end="335">Stay Informed. Stay Connected. Stay Ahead.</h3><p data-start="337" data-end="702">Join us for an exclusive three-part webinar series designed to equip clinicians, providers, and industry partners with the knowledge and tools to maximize the benefits of the <strong data-start="512" data-end="526">MyoPro® 2x</strong>. Each session dives into a critical area to help you succeed—whether it’s navigating reimbursement, discovering what’s new, or strengthening collaboration with our partners.</p><hr data-start="704" data-end="707" /><h2 data-start="709" data-end="742">Webinar 1: <strong data-start="723" data-end="740">Reimbursement</strong></h2><p data-start="743" data-end="1050"><strong data-start="743" data-end="785">Simplifying the Path to Patient Access</strong><br data-start="785" data-end="788" />Learn the latest updates and best practices for securing reimbursement for MyoPro® devices. We’ll cover practical tips, documentation essentials, and resources designed to help you streamline the approval process so more patients can access the care they need.</p><hr data-start="1052" data-end="1055" /><h2 data-start="1057" data-end="1108">Webinar 2: <strong data-start="1071" data-end="1106">What’s New About the MyoPro® 2x</strong></h2><p data-start="1109" data-end="1414"><strong data-start="1109" data-end="1149">Next-Generation Innovation in Action</strong><br data-start="1149" data-end="1152" />Discover the advanced features of the MyoPro® 2x and see how it’s setting new standards in usability and performance. We’ll explore product enhancements, patient benefits, and clinical applications that make the MyoPro 2x more powerful and effective than ever.</p><hr data-start="1416" data-end="1419" /><h2 data-start="1421" data-end="1474">Webinar 3: <strong data-start="1435" data-end="1472">Support for Our Industry Partners</strong></h2><p data-start="1475" data-end="1754"><strong data-start="1475" data-end="1496">Stronger Together</strong><br data-start="1496" data-end="1499" />This session is dedicated to our valued partners. Learn how Myomo supports you with training, marketing tools, and patient engagement resources. We’ll also share strategies to strengthen collaboration and drive impact across the rehabilitation industry.</p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-c41997a elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="c41997a" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-23ff487" data-id="23ff487" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-58170d6 elementor-widget elementor-widget-text-editor" data-id="58170d6" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
				<div class="elementor-widget-container">
									<h2 data-start="1939" data-end="1961">Reserve Your Spot</h2><p data-start="1962" data-end="2135">Choose one, two, or all three webinars—whatever fits your needs best. Don’t miss these opportunities to expand your expertise and better serve your patients and community.</p>								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				<section class="elementor-section elementor-top-section elementor-element elementor-element-2ad8443 elementor-section-boxed elementor-section-height-default elementor-section-height-default" data-id="2ad8443" data-element_type="section" data-e-type="section">
						<div class="elementor-container elementor-column-gap-default">
					<div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f88893b" data-id="f88893b" data-element_type="column" data-e-type="column">
			<div class="elementor-widget-wrap elementor-element-populated">
						<div class="elementor-element elementor-element-3dc3caf elementor-align-left elementor-widget elementor-widget-button" data-id="3dc3caf" data-element_type="widget" data-e-type="widget" data-widget_type="button.default">
				<div class="elementor-widget-container">
									<div class="elementor-button-wrapper">
					<a class="elementor-button elementor-button-link elementor-size-sm" href="mailto:marketing@myomo.com" target="_blank">
						<span class="elementor-button-content-wrapper">
									<span class="elementor-button-text">Register Now</span>
					</span>
					</a>
				</div>
								</div>
				</div>
					</div>
		</div>
					</div>
		</section>
				</div>
		<p>The post <a href="https://myomo.com/webinars/">Webinars</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://myomo.com/webinars/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		
	</item>
		<item>
		<title>Myomo Reports Second Quarter 2025 Financial and Operating Results</title>
		<link>https://myomo.com/myomo-reports-second-quarter-2025-financial-and-operating-results/</link>
					<comments>https://myomo.com/myomo-reports-second-quarter-2025-financial-and-operating-results/#respond</comments>
		
		<dc:creator><![CDATA[Ian Godzik]]></dc:creator>
		<pubDate>Mon, 11 Aug 2025 20:10:56 +0000</pubDate>
				<category><![CDATA[Press Release]]></category>
		<guid isPermaLink="false">https://myomo.com/?p=5020743</guid>

					<description><![CDATA[<p>Myomo Reports Second Quarter 2025 Financial and Operating Results &#160; Revenue of $9.7 million  816 patients added to the MyoPro pipeline Updates 2025 revenue guidance   Conference call begins today at 4:30pm Eastern time   BURLINGTON, Mass. (August 11, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company [&#8230;]</p>
<p>The post <a href="https://myomo.com/myomo-reports-second-quarter-2025-financial-and-operating-results/">Myomo Reports Second Quarter 2025 Financial and Operating Results</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><strong>Myomo Reports Second Quarter 2025 Financial and Operating Results </strong></p>
<p>&nbsp;</p>
<p><em>Revenue of $9.7 million </em></p>
<p><em> 816 patients added to the MyoPro pipeline </em></p>
<p><em>Updates 2025 revenue guidance</em></p>
<p><em> </em></p>
<p><em>Conference call begins today at 4:30pm Eastern time</em></p>
<p><em> </em></p>
<p><strong>BURLINGTON, Mass. (August 11, 2025) – Myomo, Inc. (NYSE American: MYO)</strong> (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and six months ended June 30, 2025.</p>
<p>Financial and operating highlights for the second quarter of 2025 include the following (all comparisons are with the second quarter of 2024 unless otherwise indicated): <a href="https://myomo.com/wp-content/uploads/2025/08/Myomo-Q2-2025-Earnings-PR.pdf">Read more.</a></p>
<p>The post <a href="https://myomo.com/myomo-reports-second-quarter-2025-financial-and-operating-results/">Myomo Reports Second Quarter 2025 Financial and Operating Results</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://myomo.com/myomo-reports-second-quarter-2025-financial-and-operating-results/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		
	</item>
		<item>
		<title>Myomo to Report Second Quarter 2025 Financial Results on August 11</title>
		<link>https://myomo.com/myomo-to-report-second-quarter-2025-financial-results-on-august-11/</link>
					<comments>https://myomo.com/myomo-to-report-second-quarter-2025-financial-results-on-august-11/#respond</comments>
		
		<dc:creator><![CDATA[Ian Godzik]]></dc:creator>
		<pubDate>Mon, 04 Aug 2025 20:17:24 +0000</pubDate>
				<category><![CDATA[Press Release]]></category>
		<guid isPermaLink="false">https://myomo.com/?p=5020723</guid>

					<description><![CDATA[<p>BURLINGTON, Mass. (August 4, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the second quarter of 2025 on Monday, August 11, 2025.  Management will hold [&#8230;]</p>
<p>The post <a href="https://myomo.com/myomo-to-report-second-quarter-2025-financial-results-on-august-11/">Myomo to Report Second Quarter 2025 Financial Results on August 11</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><strong>BURLINGTON, Mass. (August 4, 2025) – Myomo, Inc.</strong> (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the second quarter of 2025 on Monday, August 11, 2025.  Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions.</p>
<p>&nbsp;</p>
<p>Participants are encouraged to pre-register for the conference call using this <a href="https://dpregister.com/DiamondPassRegistration/register?confirmationNumber=10201788&amp;linkSecurityString=ffa8d2ccfc">link</a> to receive a dial-in number and PIN to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those unable to pre-register can participate by dialing 844-707-6932 (U.S.) or 412-317-9250 (International). A webcast of the call can be accessed at <a href="https://ir.myomo.com/">https://ir.myomo.com/</a>. <a href="https://myomo.com/wp-content/uploads/2025/08/Myomo-Second-Quarter-2025-Earnings-Call.pdf">Read More.</a></p>
<p>The post <a href="https://myomo.com/myomo-to-report-second-quarter-2025-financial-results-on-august-11/">Myomo to Report Second Quarter 2025 Financial Results on August 11</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://myomo.com/myomo-to-report-second-quarter-2025-financial-results-on-august-11/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		
	</item>
		<item>
		<title>Myomo Provides Highlights of Today’s Investor &#038; Analyst Day Event</title>
		<link>https://myomo.com/myomo-provides-highlights-of-todays-investor-analyst-day-event/</link>
		
		<dc:creator><![CDATA[Ian Godzik]]></dc:creator>
		<pubDate>Wed, 18 Jun 2025 12:58:26 +0000</pubDate>
				<category><![CDATA[Press Release]]></category>
		<guid isPermaLink="false">https://myomo.com/?p=5020499</guid>

					<description><![CDATA[<p>Senior executives to provide an in-depth review of the Company’s business model and discuss long-range aspirational financial metrics BURLINGTON, Mass. (June 18, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, will host an Investor [&#8230;]</p>
<p>The post <a href="https://myomo.com/myomo-provides-highlights-of-todays-investor-analyst-day-event/">Myomo Provides Highlights of Today’s Investor &#038; Analyst Day Event</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><strong><em>Senior executives to provide an in-depth review of the Company’s business model and discuss long-range aspirational financial metrics</em></strong></p>



<p><strong>BURLINGTON, Mass. (June 18, 2025) – Myomo, Inc. (NYSE American: MYO)</strong> (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, will host an Investor &amp; Analyst Day event today from 10 a.m. to 3 p.m. Eastern time during which management will provide an in-depth review of the Company’s business model, provide a tour of its new headquarters and manufacturing facility and discuss long-range aspirational financial metrics.  A live and archived webcast of the event is <a href="https://event.choruscall.com/mediaframe/webcast.html?webcastid=u0VOaB46">available here</a>. To be held in Burlington, Mass. and virtually, highlights include the following: <a href="https://myomo.com/wp-content/uploads/2025/06/Myomo-Analyst-Day-PR.pdf">Read More:</a></p>
<p>The post <a href="https://myomo.com/myomo-provides-highlights-of-todays-investor-analyst-day-event/">Myomo Provides Highlights of Today’s Investor &#038; Analyst Day Event</a> appeared first on <a href="https://myomo.com">Myomo</a>.</p>
]]></content:encoded>
					
		
		
		
	</item>
	</channel>
</rss>

<!--
Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/?utm_source=w3tc&utm_medium=footer_comment&utm_campaign=free_plugin

Page Caching using Disk: Enhanced 

Served from: myomo.com @ 2026-04-11 06:37:20 by W3 Total Cache
-->